The authors reply

Affiliations

¹ Department of Internal Medicine, College of Medicine, Seoul National University, Seoul, Korea; Department of Internal Medicine, Inje University Ilsan Paik Hospital, Ilsan, Korea.
² Department of Kidney Research Institute, Seoul National University, Seoul, Korea.
³ Department of Internal Medicine, College of Medicine, Seoul National University, Seoul, Korea; Department of Kidney Research Institute, Seoul National University, Seoul, Korea; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. Electronic address: dkkim73@gmail.com.

Free article

Comment

Hyung Ah Jo et al. Kidney Int. 2021 Sep.

Free article

. 2021 Sep;100(3):707-708.

doi: 10.1016/j.kint.2021.04.012.

¹ Department of Internal Medicine, College of Medicine, Seoul National University, Seoul, Korea; Department of Internal Medicine, Inje University Ilsan Paik Hospital, Ilsan, Korea.
² Department of Kidney Research Institute, Seoul National University, Seoul, Korea.
³ Department of Internal Medicine, College of Medicine, Seoul National University, Seoul, Korea; Department of Kidney Research Institute, Seoul National University, Seoul, Korea; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. Electronic address: dkkim73@gmail.com.

No abstract available

Comment on

Fumarate modulates phospholipase A2 receptor autoimmunity-induced podocyte injury in membranous nephropathy.
Jo HA, Hyeon JS, Yang SH, Jung Y, Ha H, Jeong CW, Kwak C, Kim Y, Lee H, Lee JP, Joo KW, Lim CS, Kim YS, Hwang GS, Kim DK. Jo HA, et al. Kidney Int. 2021 Feb;99(2):443-455. doi: 10.1016/j.kint.2020.06.031. Epub 2020 Jul 23. Kidney Int. 2021. PMID: 32712166
Fumarate in membranous nephropathy: more questions than answers.
Borza DB. Borza DB. Kidney Int. 2021 Sep;100(3):707. doi: 10.1016/j.kint.2021.03.035. Kidney Int. 2021. PMID: 34420662 No abstract available.